Respiratory viruses
2 trials- 2022MELODYRSV in infantsIn 1,490 healthy late-preterm and term infants, a single intramuscular dose of nirsevimab reduced medically attended RSV-associated lower-respiratory-tract infection compared with placebo.
- 2018CAPSTONE-1InfluenzaIn 1,436 outpatients aged 12–64 with uncomplicated influenza, a single dose of baloxavir shortened time to symptom alleviation compared with placebo with much faster viral-load decline.